MARKET

JUNS

JUNS

JUPITER NEUROSCIENCES, INC.
NASDAQ
0.2800
+0.0434
+18.34%
After Hours: 0.2095 -0.0705 -25.18% 19:59 06/26 EDT
OPEN
0.2336
PREV CLOSE
0.2366
HIGH
0.2982
LOW
0.2325
VOLUME
22.36M
TURNOVER
--
52 WEEK HIGH
3.330
52 WEEK LOW
0.1721
MARKET CAP
13.50M
P/E (TTM)
-1.0728
1D
5D
1M
3M
1Y
5Y
1D
12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga · 1d ago
Jupiter Neurosciences Registers Resale Of Up To 16M Shares By Selling Stockholders
Benzinga · 1d ago
Jupiter Neurosciences files to sell 16M shares of common stock for holders
TipRanks · 1d ago
JUPITER NEUROSCIENCES - FILES FOR RESALE OF UP TO 16 MLN SHARES BY SELLING STOCKHOLDER - SEC FILING
Reuters · 1d ago
Jupiter Neurosciences Announces Board Member Resignation and Vacancy
TipRanks · 5d ago
Jupiter Neurosciences director Allison Brady resigns from board, committees
PUBT · 5d ago
Weekly Report: what happened at JUNS last week (0615-0619)?
Weekly Report · 5d ago
Weekly Report: what happened at JUNS last week (0608-0612)?
Weekly Report · 06/15 09:16
More
About JUNS
Jupiter Neurosciences, Inc. is a clinical-stage research and development pharmaceutical company. The Company has developed a resveratrol platform product targeting the treatment of neuro-inflammation. Its product, JOTROL, has many potential indications of use for rare diseases, which primarily targets Mucopolysaccharidoses Type 1, Friedreich's Ataxia, and Mitochondrial Encephalopathy, Lactic Acidosis, and Stroke-like episodes (MELAS). In the larger disease areas, it primarily targets Parkinson’s Disease and Mild Cognitive Impairment/early Alzheimer’s disease. The Company has designated the different indications with project numbers, JNS101 - JNS115. JOTROL is a micellar non-aqueous solution of resveratrol delivered in a soft gel capsule. Each capsule includes 100mg of resveratrol. It has a worldwide license from Aquanova AG, the patent holder of micellar technologies, to develop, manufacture, distribute and sell JOTROL.

Webull offers Jupiter Neurosciences Inc stock information, including NASDAQ: JUNS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, JUNS stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading JUNS stock methods without spending real money on the virtual paper trading platform.